MatthewEbiaMD

Oncology • Los Angeles, CA

Physician

Join to view full profile

Dr. Ebia is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Ebia's full profile

Already have an account?

Office
116 N Robertson Blvd
Los Angeles, CA 90048

Education & Training

University of Southern California/Los Angeles General Medical Center (USC/LA General)Residency, Internal Medicine, 2019 - 2022
Northwestern University The Feinberg School of MedicineClass of 2019

Certifications & Licensure

CA State Medical License 2022 - 2026
American Board of Internal Medicine Internal Medicine

Publications & Presentations

PubMed

Early dose reduction of osimertinib in advanced EGFR -mutated non-small cell lung cancer.
Marion Ferreira, Matthew I Ebia, Karen L Reckamp
Anti-Cancer Drugs. 2024-08-01
3 citations
TOPAZ-1: a new standard of care for advanced biliary tract cancers?
Matthew I Ebia, Kamya Sankar, Arsen Osipov, Andrew E Hendifar, Jun Gong
Immunotherapy. 2023-05-01
2 citations
Immunotherapy for deficient mismatch repair (dMMR) pancreatic ductal adenocarcinoma.
Matthew I Ebia, Megan P Hitchins, Andrew E Hendifar
Journal of Gastrointestinal Oncology. 2023-04-29

Journal Articles

Dermatologic Reactions to Novel Immune Checkpoint Inhibitors
Matthew I. Ebia, J. Choi, Current Dermatology Reports, 10/24/2018